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There is limited data regarding women who inject drugs, and how harm-reduction services 
can be made more women-centered. This study explored experiences of Kenyan women who 
inject drugs, with regard to access to HIV, harm reduction and sexual and reproductive health 
(SRH) services. A total of 45 women who inject drugs and 5 key stakeholders participated in-
depth interviews and focus group discussions. Thematic analysis of the data revealed that 
stigma, long distances, lack of confidentiality, user fees, multiple appointments, drug users’ 
unfamiliarity with health facilities, disconnect in communication with healthcare providers, 
and healthcare providers’ lack of understanding of women’s needs were factors that impede 
women’s access to health services. Community-based services, comprising of outreach and 
drop-in centers mitigate these barriers by building trust, educating women on their health and 
rights, linking women to health facilities, sensitizing health providers on the needs of women 
who inject drugs, and integrating women’s SRH services into community-based harm-
reduction outreach. Inclusion of SRH services into community-based harm-reduction 
activities increased women’s interest and access to harm-reduction interventions. These 
findings underscore the need to strengthen community-based programming for women who 
inject drugs, and to integrate SRH services into needle and syringe exchange programs.  
 
 




Human Immunodeficiency Virus (HIV) is a significant cause of morbidity globally. In Kenya 
HIV is generalized, with a national prevalence of 5.6% (NACC, 2014). Although HIV is 
predominantly transmitted via heterosexual sex, importance of injecting drug use (IDU) is 
emerging (NASCOP, 2014; Petersen, Myers, van Hout, Pluddemann, & Parry, 2013). Almost 
a fifth (18.7%), of all 18,327 injecting drug users nationally are infected with HIV (NACC, 
2014; Tun et al., 2015). Within this IDU-related HIV epidemic, gender and geographic 
disparities exist. Prevalence is higher at the coast and among women (Kurth et al., 2015; Tun 
et al., 2015).  
Globally, women who inject drugs (WWID) face unique vulnerabilities. Compared to 
men, they are more likely to be homeless, have more sexual partners, and engage in sex work 
(Lambdin et al., 2013; Williams et al., 2007). Overlapping sexual relationships affect 
women’s injecting risks more than they affect men (Evans et al., 2003). Additionally, gender 
vulnerabilities prevent WWID from accessing services. For instance, WWID face stronger 
stigma from their communities and health professionals (Azim, Bontell, & Strathdee, 2015). 
Due to sociocultural reasons, they rarely gather at outdoor areas where male injectors 
congregate, which prevents them from being reached by outreach interventions (Zamudio-
Haas, Mahenge, Saleem, Mbwambo, & Lambdin, 2016). Few WWID access antenatal 
services which are a spring board for HIV and child services (Peters et al., 2003). 
Consequently, WWID are less likely to enter drug treatment compared to men (Greenfield et 
al., 2007). Besides affecting their own health, women’s injecting drug use has negative 
consequences on their children’s well being (Howell, Heiser, & Harrington, 1999).  
To mitigate harms of injecting drug use, a comprehensive package of harm reduction 
interventions is recommended for all injecting drug users (WHO, UNODC, & UNAIDS, 
  
2009). This package includes needle and syringe exchange programs (NSP); opioid 
substitution therapy (OST); education interventions; and, prevention, diagnosis and treatment 
of hepatitis, tuberculosis (TB), HIV and other sexually transmitted infections (STIs) (WHO et 
al., 2009). In Kenya, a harm reduction approach was incorporated into the national HIV 
strategy in 2013, following which harm reduction interventions were introduced in public 
facilities (NASCOP, 2013). 
Precise data on WWID’s access to harm reduction services in Kenya are lacking. 
However, anecdotal observations suggest that gender-related inequalities in service access 
exist. While is essential to provide gender-sensitive services to WWID, provision of sexual 
and reproductive health (SRH) services, including contraception is limited (Mburu et al., In 
Press). 
Given the known difficulties of accessing conventional health services by WWID 
(Hunter & Judd, 1998), community-based outreach programs could be a particularly useful 
for reaching them, especially if they are tailored to their needs, and are socially, rather than 
just bio-medically oriented. In spite of their potential utility in reaching WWID, majority of 
community-based outreach programs are not adapted to WWID’s SRH and social 
circumstances (Armstrong, 2017; Lambdin et al., 2013; Pinkham, Stoicescu, & Myers, 2012).  
In Kenya, there is little experience and documentation regarding WWID, which is to 
be expected, given the nascent nature of harm reduction programming nationally. However, 
there is a need to identify effective approaches of providing tailored services to WWID. This 
paper reports experiences of WWID accessing conventional health services, as well as 
community-based based harm reduction outreach services that had been designed to be more 
women-centered.  
Methods  
Study design  
  
Data were generated from a 2015 qualitative study conducted in Kilifi and Mombasa.  
Study setting  
In these two coastal towns, harm reduction interventions were being provided to injecting 
drug users through community-based outreach by three community-based organisations 
(CBOs): Kenya AIDS NGOs Consortium (KANCO), Reach out Centre Trust (REACH OUT) 
and the Muslim Education and Welfare Association (MEWA). As opposed to relying on drug 
users to seek health facilities, outreach brought services to them. Each outreach team 
comprised of a lead outreach worker and 3-4 peer educators, some of whom were former 
drug users.  
Outreach services were complemented with services at drop in-centers, as is the case 
in other countries (Ti et al., 2015; Zamudio-Haas et al., 2016). A key feature of the drop-in 
centers was their informality, closeness and familiarity to drug users. At drop-in centers, 
services were provided by multi-disciplinary teams comprising of managers, coordinators, 
counsellors, clinical officers, nurses and paralegals.  
Services and interventions  
The above services were initiated in mid-2012. In 2014, the program was expanded to 
include gender-sensitive SRH interventions (Table 1). 
Table 1. Services provided to women who inject drugs at the study sites. 
Service domain. Services provided through 
community outreach. 
Services provided at 
drop-in centres. 
Referrals to private or 
government health and 
social services. 
Prevention and 
treatment of HIV 
and co-infections.  
Condoms, HIV testing, 
information, communication 
and education on HIV and 
STIs. 
HIV testing and 
counselling.  
Referrals for confirmation 
of HIV status, and 




Clean needles and syringes, 
alcohol swabs, cotton wool. 
Addiction counselling, and 
first aid for violence or 
overdose. 
Referrals for OST/ 
medication-assisted 






Information on family 
planning, provision of 
hygiene packages/tampons 
and oral contraceptive pills. 
Antenatal education, sister-
to-sister counselling, and 
provision of oral 
contraceptive pills.  
Referrals for long-acting 
contraceptives, antenatal 
care, and cervical cancer 
screening. 
Social and child 
care related 
services. 
Transportation to health 
facilities, and provision of 
personal care kits. 
Personal care (shower, 
soap, toothbrush/paste, 
lotions), meals, short-term 
shelter, and diapers for 
children. 
Referrals for post-sexual 
violence services, 
including legal assistance. 
 
Participant recruitment  
WWID were invited to participate by outreach workers, were screened, and based on 
availability, scheduled for IDIs or FGDs. To participate, women had to be aged ≥18 years, be 
within reproductive age bracket of 18–49 years, and have injected drugs within 90 days. For 
triangulation purposes, several stakeholders were purposively selected to participate, based 
on their expertise in providing services to injecting drug users. 
Data collection 
IDIs and FGDs explored drug use, SRH, HIV, and participants’ experiences with outreach or 
conventional government health services. Data were collected by two experienced 
researchers and speakers of Swahili (SA and JN) in private rooms at drop-in centers, or at key 
stakeholders’ offices. All IDIs and FGDs were conducted in Swahili or English. IDIs and 
FGDs were audio recorded and lasted 45-60 minutes. At the end of the IDIs and FGDs, a 
brief questionnaire was used to collect socio-demographic data. 
Data analysis 
Thematic analysis was conducted (Bryman, 2012). IDI and FGD data were transcribed in 
English. Transcripts were imported into Nvivo® (Bazeley, 2007), and used to generate initial 
nodes and codes independently by GM and JN. These were compared, and differences 
  
resolved through consensus. Preliminary codes were refined by GM through constant 
comparison (Silverman, 2001) and categorized to generate descriptive and analytical themes 
(Bryman, 2012; Charmaz, 2000). 
Ethical considerations 
Informed consent was obtained from participants, who retained a right to withdraw at any 
time. Ethics committee of the National Commission for Science Technology and Innovation 
authorized the study (P/15/8861/4510). 
Results 
Participant characteristics  
Overall, 45 WWID took part: 24 participated in IDIs (12 per site) and 21 attended three 
FGDs (2 sessions in Mombasa and 1 session in Kilifi) (Table 2). Additionally, 5 key 
stakeholders, of whom three were women, participated. These included a community health 
worker (n=1), outreach workers (n=2), a ministry of health official (n=1) and a CBO manager 
(n=1).  







(n=45)  % 
Age (mean, years) 26.4 30.5 28.4 - 
Number of children (mean)   1.6 - 
Education 
None 4 4 8 18% 
Primary  13 10 23 51% 
Secondary 6 6 12 27% 
Post-secondary 0 1 1 2% 
Unknown 1 0 1 2% 
Marital status 
Married 5 3 8 18% 
Live in partner 7 5 12 27% 
  
Single 11 13 24 53% 
Unknown 1 0 1 2% 
Income source 
Casual labor 2 5 7 16% 
Food Kiosk/plaiting 3 2 5 11% 
Sex work 9 4 13 29% 
Peddling 1 2 3 7% 
Peer educator 0 1 1 2% 
Family or partner 3 1 4 9% 
Begging, hustling 5 6 11 24% 
Unknown 1 0 1 2% 
Drug use 
Duration using drugs (years) 7.8 9.1 8.5 - 
Duration injecting (years) 3.3 2.0 2.6 - 
Main drugs used 
Heroin 11 1 12 27% 
Heroin, and other drugs 11 15 26 58% 
Cocaine 1 3 4 9% 
Cocaine and other drugs  1 2 3 6% 
 
Emerging themes 
Descriptive themes were related to barriers and facilitators to health service access by 
WWID. Specifically, data pointed to a range of barriers which were experienced largely 
within conventional health services, and a range of facilitating factors, mostly emanating 
from outreach services, which enabled them to access essential services. An emerging 
analytical theme was related to the integration of SRH services in harm reduction programs. 
 
Participants’ experiences with conventional health services: barriers to access to services 
  
Several barriers to accessing conventional health services emerged. To start with, participants 
encountered stigmatizing attitudes at conventional health facilities. Denoting her interactions 
with health providers, a participant reported that “they despise us a lot.” She added that: 
Should they know that you are an addict, they send you backwards on the queue or 
tell you to go and come later. (Participant # 10, Kilifi). 
As noted above, WWID were frequently isolated and often served last. One participant 
asserted that “they tell each other “that is a drug user”, they take you round from one place 
to another once they know you are a drug user, and you end up being the last one to be 
served.” (Participant # 5, Kilifi). A stakeholder explained that negative interactions occurred 
because “the health care workers did not understand why and how they needed to serve 
female drug users”. (Stakeholder # 3, Kilifi).  
This stigmatization meant that some participants had “never gone back” (Participant # 
10, Kilifi). Others attempted to hide their drug-using identity at health facilities: 
I was forced to tell the truth that I was an addict. It was by luck that I meet a good 
nurse. Had I have found the wrong one, I would have been insulted a lot, and not 
attended to. (Participant # 10, Mombasa). 
Long queues at health facilities were described as particularly difficult to navigate, 
especially when experiencing drug withdrawals: 
Since I had ‘arosto’ [drug withdrawal] and could not queue, I just left. (Participant # 
10, Mombasa). 
Additionally, lack of privacy and frequent interruptions in counselling rooms was a barrier, 
especially in relation to HIV services: 
I was talking to that counselor and people kept coming into her office. When someone 
comes in, you freak; you fear that maybe they have known what is going on. 
(Participant # 8, Mombasa). 
  
Often, participants had to travel by public transport to access services, which was a 
barrier. One participant rhetorically asked “will you take 40 shillings to go to the hospital or 
will you first look for drugs?” (Participant # 5, Kilifi). WWID’s de-prioritization of their 
healthcare was often exacerbated by user-fees: 
The provider who injects…told me to give out 50 shilling so that I can be injected. I 
told him I don’t have. I wasn’t injected. (Participant # 5, Kilifi). 
Lastly, multiple appointments were blamed for missed services. Participants rued having to 
remember different appointment dates, yet given their drug use, they were not very adept at 
remembering multiple dates: 
I went last week…first they gave me an appointment on the following day. On the 
day, I remembered when it was late. Now they told me there is another date, so I’m 
now waiting for the next appointment, although I have not confirmed on what day it 
will be, but I will go there today to confirm. (Participant # 1, Kilifi).
  
Table 3. Barriers in accessing conventional health services and the role of outreach in mitigating them. 
Theme Health system 
related barrier 
Outreach elements 




Trust, and personal 
support. 
The outreach workers are okay. They don’t have anything against us. If you have 
problems, you tell them; they will help you. (Participant # 6, Kilifi). 




They visit us, educate us, and bring us condoms and needles. (Participant # 6, 
Mombasa). 
Convenience. Long queues, and 
‘seen last’. 
Referral slips that 
facilitate access to 
services. 
Immediately they see this paper from REACHOUT they treat you with respect; if you 
don’t have it, you can be really mistreated. (Participant # 12, Mombasa). 
Confidentiality. Lack of privacy in 
health clinics. 
Confidential with drug 
use information. 
The outreach workers will not leave you if you get any problem …you could get sick 
because you are addicted to drugs…they will attend to you without telling on you. 
(Participant # 7, Mombasa). 
Cost. User fees. Fee-free referral 
vouchers. 
People from REACHOUT will write a referral to go to a certain hospital. Because of 






with the needs of 
drug users. 
Use of outreach 
workers/ peer educators 
who understand 
women’s needs. 
When you get to the hospital they connect you to health care workers. The outreach 








If you come along with an outreach worker they give you the required services but if 





We go to the field to remind them that they have to come. (Stakeholder # 1, Kilifi). 
Unlinked vertical 
services. 
Integrated services. We perform blended outreach where we bring them together and offer them health 
services related to reproductive health, TB, hepatitis and HIV. (Stakeholder # 1, Kilifi) 
  
Value of outreach services in increasing access to harm reduction, HIV and reproductive 
services 
Participants valued outreach teams as a source of information, reporting outreach workers 
“come and educate us” regarding “protection from infections” (Participant # 7, Mombasa) or 
“how to stop drug addiction and to go to rehabilitation” (Participant # 11, Kilifi). 
Participants highlighted how outreach brought commodities such as injecting needles, 
syringes, HIV testing, condoms and combined oral contraceptive pills directly to them. A 
participant stated that “they visit us in our residence, bringing us syringes and needles” 
(Participant # 11, Kilifi). Free transport and appointment reminders were regularly offered by 
outreach workers as illustrated in Table 3. In other cases, outreach workers collected drugs 
on behalf of WWID who were experiencing difficulties:  
The outreach people help us; sometimes they take the medicines for us and they bring 
it to [our] dens. (Participant # 5, Kilifi). 
While free transport was important, it was accompaniment to health facilities by 
outreach teams that was a highly regarded as it often meant that women were “given free 
services” and were not “looked down upon” (Participant # 5, Kilifi). This was particularly 
important given that as shown in Table 2, most WWID were unemployed. Accompaniment 
was particularly valuable as outreach workers - including peer educators who were former 
drug users - understood drug users’ problems well and hence mediated communications with 
health care workers while at the same time enabling WWID to navigate unfamiliar health 
facilities. Because most WWID were uneducated as illustrated in Table 2, they appreciated 
having someone “who will be in front at the doctor” or who could “talk” and explain their 
health needs to health providers, (Participant # 5, Kilifi). Outreach workers were familiar 
with lingo used by both WWID and healthcare providers, and were therefore well positioned 
to mediate this communication. When accompaniment was not possible, referral slips and 
  
vouchers from outreach workers ‘unlocked doors’, and enabled women to be treated with 
respect as described in Table 3.  
In contrast to the fear of breach of confidentiality, stigmatisation and social distancing 
associated with health facilities, outreach workers had gained participants’ trust, which 
according to one participant was due to “the way they treat us well; they do not isolate us” 
(Participant # 7, Kilifi). Describing her interaction with outreach workers, a participant 
described that it was common to “meet them if you have any problem” and discuss sensitive 
matters including “sexual issues, in case there is someone who has sexually assaulted you” 
(Participant # 8, Kilifi). Positive perceptions were also reported in relation to a range of 
psychosocial support provided at drop-in centers as illustrated in Table 1. For instance, one 
participant remarked that “they were giving us food, and clothes; if you come here you are 
free to have a bath” (Participant # 7, Mombasa). 
Integration of reproductive health services as an additional incentive for harm reduction 
services 
Inclusion of SRH services in the outreach program leveraged on the motivation for 
contraception and need for childcare among WWID, and attracted them to harm reduction 
services, including drop-in centers: 
I have seen change as an outreach worker. I have seen them improve in terms of their 
interest in needles and syringes because of this sexual and reproductive program. 
(Stakeholder # 2, Kilifi). 
These findings were supported by a program manager, who asserted that “we have seen that 
clients themselves are very committed; they want these services.” (Stakeholder # 3, Kilifi). 
Before inclusion of SRH services, providing appropriate services for WWID was said to be 
difficult: 
  
We didn’t have a specific package for females, and there was no project that was 
addressing issues of women. (Stakeholder # 1, Mombasa). 
In contrast to the previous situation, integration of SRH into harm reduction was seen as 
“bringing about positive change” as it was “benefitting a lot of women who have SRH needs 
that for a long time remained unaddressed.” (Stakeholder # 1, Mombasa).  
Discussion 
Women who inject drugs are known to have low access to harm reduction services and other 
essential health services. Our study documents specific barriers that prevent WWID’s access 
to health services at the Kenyan Coast. These barriers are not necessarily surprising, and they 
add on existing literature regarding barriers of access to health services among drug users in 
general (Appel, Ellison, Jansky, & Oldak, 2004; Appel & Oldak, 2007; Bobrova et al., 2006; 
Guise, Rhodes, Ndimbii, Ayon, & Nnaji, 2016; Mlunde et al., 2016; Nambiar, Stoove, & 
Dietze, 2014) and specifically women (Azim et al., 2015; Khuat, Morrow, Nguyen, & 
Armstrong, 2015; Zamudio-Haas et al., 2016).  
At the same time, our study shows the value of community-based outreach services in 
mitigating these barriers and facilitating access to harm reduction and SRH services. Our 
findings corroborate studies documenting the value of outreach and peer-based approaches in 
facilitating access to NSP and HIV services for drug users (Guise et al., 2016; Hayashi et al., 
2015; Morgan, Lee, & Sebar, 2015; Ti et al., 2015), including women (Zamudio-Haas et al., 
2016). 
A unique contribution of our study is in advancing literature related to potential 
contribution of outreach services as strategy for integrating gender-sensitive SRH services 
within harm reduction programs. In our study context, integrating SRH services increased 
demand for harm reduction services, which is particularly relevant given existing gap in 
contraception and other SRH services for WWID (Mburu et al., In Press). Integrating harm 
  
reduction with HIV services has been called for by others (Armstrong, 2017; Bachireddy et 
al., 2014; Guise et al., 2017; Pinkham et al., 2012), and additionally we argue, integration of 
SRH services offered through outreach is acceptable in our study setting. In a rare study 
examining this issue Armstrong, Kenen, and Samost (1991) found that integrating SRH and 
drug treatment was feasible. Integration of other services may be increasingly needed to 
ensure a holistic response to the health and social circumstances of women. For instance, 
drop-in centers have been used as a space to provide nutritional, self-care and other social 
support (Kerr et al., 2010; Ti et al., 2015). In our context, provision childcare interventions 
enhanced the utility drop-in centres for WWID with children. 
Implications for programs and policy 
Given this value and demand-creating potential, integrating SRH into harm reduction 
would be an effective strategy for increasing uptake of harm reduction services by WWID. 
Our argument is not to necessarily have women-only drug treatment programs as Kermode, 
Songput, Sono, Jamir, and Devine (2012) call for, but rather to include program elements that 
address the unique SRH needs of WWID. The choice of women-only programs should be 
based on the population size of WWID in each context (Armstrong et al., 1991), bearing in 
mind that women-only treatment is not necessarily more effective than mixed-gender 
treatment (Greenfield et al., 2007). However, harm reduction programs that address unique 
needs of drug-using women have been shown to be effective (Greenfield et al., 2007), 
acceptable (Armstrong et al., 1991) and beneficial to children of WWID (Pinkham et al., 
2012). 
We hypothesize that services for WWID in our context could be further improved by 
the inclusion of additional gender-sensitive services, such as engaging women as outreach 
workers and peer educators, further sensitizing health providers regarding unique needs of 
WWID, supporting WWID to access MAT/OST, strengthening interventions related to 
  
gender-based violence, strengthening referrals for immunization and post-natal care of 
children of WWID, creating opportunities for screening of minor ailments of children of 
WWID at drop-in centers, and creating opportunities for economic empowerment for WWID. 
Future research should document the precise nature of services that WWID desire. 
Nevertheless, addressing these needs will require cross-sectoral collaboration between social 
and health services, paralleling diverse social and structural determinants of health and well-
being of WWID and their families. 
Limitations 
Generalizability of our findings is limited by convenience sampling. Our participants were in 
contact with outreach services, and their behaviours differ from those not reached by 
outreach (Coyle, Needle, & Normand, 1998). Their responses may have been influenced by 
social desirability bias given that they were recruited by outreach workers in the same 
program they were asked to discuss.  
Conclusion 
WWID are more likely than men to face multiple barriers preventing their access to harm 
reduction and other essential services (Tuchman, 2010). Increasing women’s access to 
comprehensive services is likely to curb HIV infections, improve their quality of life, enable 
achievement of national and global HIV and hepatitis prevention goals. Our findings show 
that outreach has a role in increasing access to harm reduction services, and that integrating 
SRH services into harm reduction services can increase demand and motivation of WWID to 
use harm reduction interventions, and could potentially improve the welfare of their children.  
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